Terms: = Brain cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1 AND Prognosis
8 results:
1. Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma.
Li H; He J; Li M; Li K; Pu X; Guo Y
Front Immunol; 2022; 13():1027631. PubMed ID: 36532035
[TBL] [Abstract] [Full Text] [Related]
2. MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors.
Shahab S; Rubens J; Kaur H; Sweeney H; Eberhart CG; Raabe EH
J Neuropathol Exp Neurol; 2020 Jul; 79(7):746-753. PubMed ID: 32472116
[TBL] [Abstract] [Full Text] [Related]
3. EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP).
Cardona AF; Rojas L; Zatarain-Barrón ZL; Freitas HC; Granados ST; Castillo O; Oblitas G; Corrales L; Castro CD; Ruiz-Patiño A; Martín C; Pérez MA; González L; Chirinos L; Vargas C; Carranza H; Otero J; Rodriguez J; Rodriguez J; Archila P; Lema M; Acosta Madiedo J; Karachaliu N; Wills B; Pino LE; de Lima V; Rosell R; Arrieta O;
Lung Cancer; 2018 Nov; 125():265-272. PubMed ID: 30429031
[TBL] [Abstract] [Full Text] [Related]
4. Genomic characterization of primary central nervous system lymphoma.
Fukumura K; Kawazu M; Kojima S; Ueno T; Sai E; Soda M; Ueda H; Yasuda T; Yamaguchi H; Lee J; Shishido-Hara Y; Sasaki A; Shirahata M; Mishima K; Ichimura K; Mukasa A; Narita Y; Saito N; Aburatani H; Nishikawa R; Nagane M; Mano H
Acta Neuropathol; 2016 Jun; 131(6):865-75. PubMed ID: 26757737
[TBL] [Abstract] [Full Text] [Related]
5. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract] [Full Text] [Related]
6. Favourable prognosis in medulloblastoma with extensive nodularity is associated with mitogen-activated protein kinase upregulation.
Jóźwiak J; Sontowska I; Bikowska B; Grajkowska W; Galus R; Roszkowski M
Folia Neuropathol; 2011; 49(4):257-61. PubMed ID: 22212915
[TBL] [Abstract] [Full Text] [Related]
7. Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BAD.
Grund K; Ahmadi R; Jung F; Funke V; Gdynia G; Benner A; Sykora J; Walczak H; Joos S; Felsberg J; Reifenberger G; Wiestler OD; Herold-Mende C; Roth W
Cancer Biol Ther; 2008 Dec; 7(12):1982-90. PubMed ID: 19158480
[TBL] [Abstract] [Full Text] [Related]
8. Signaling from p53 to NF-kappaB determines the chemotherapy responsiveness of neuroblastoma.
Armstrong MB; Bian X; Liu Y; Subramanian C; Ratanaproeksa AB; Shao F; Yu VC; Kwok RP; Opipari AW; Castle VP
Neoplasia; 2006 Nov; 8(11):967-77. PubMed ID: 17132229
[TBL] [Abstract] [Full Text] [Related]
